Lannett (NYSE:LCI) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Lannett (NYSE:LCIGet Rating) in a report released on Friday. The brokerage set a “hold” rating on the stock.

Lannett stock opened at $0.60 on Friday. Lannett has a 12 month low of $0.45 and a 12 month high of $5.09. The business has a 50 day simple moving average of $0.61 and a 200-day simple moving average of $1.04. The stock has a market capitalization of $25.94 million, a PE ratio of -0.08 and a beta of 1.19.

Several institutional investors have recently added to or reduced their stakes in LCI. GSA Capital Partners LLP purchased a new stake in shares of Lannett during the first quarter worth approximately $29,000. Walleye Trading LLC purchased a new stake in shares of Lannett during the fourth quarter worth approximately $29,000. First Quadrant LLC CA purchased a new position in Lannett in the first quarter worth $35,000. Goldman Sachs Group Inc. raised its position in Lannett by 163.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 38,058 shares of the company’s stock worth $62,000 after acquiring an additional 23,629 shares in the last quarter. Finally, Virtu Financial LLC purchased a new position in Lannett in the fourth quarter worth $65,000. Institutional investors and hedge funds own 60.51% of the company’s stock.

About Lannett (Get Rating)

Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages.

See Also

Want More Great Investing Ideas?

Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.